Stock market analyst Ashwani Gujral has suggested investors to purchase ‘Orchid Chem’ stock to achieve short term target of Rs 400. It is looking very strong, and grasp it as much as you can.

The stock has performed in the previous trading sessions. Today, it opened at Rs 302 as compared to its Friday closure at Rs 294.70. Presently (1:00 pm), it is trading 0.25% down at Rs 293.95.

On Bombay Stock Exchange, the stock today has touched a new 52-week high of Rs 302. The investors can purchase the stock around Rs 278 with a stop loss of Rs 265. With an EPS of Rs 25.39, the stock is trading with a P/E of 11.58.

The stock will surely achieve the said target within a period of 4-5 weeks. So, the investors are suggested not to sell this stock before achieving this target.

Orchid Chem has been performing well based on better results in previous quarter. The fundamentals are too strong and it has robust plans for the future growth in profits.

If investors want some other options in the same segment, they can purchase Cipla, Ranbaxy Labs, Glenmark and Sun Pharma.for short or medium term. The pharma segment is looking good at the moment, and there are also great expectations in the coming days.